Cargando…
Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series
INTRODUCTION: Invasive fungal infections have been attracting attention as significant fatal complications in patients with febrile neutropenia (FN) who undergo intensive chemotherapy or hematopoietic stem cell transplantation to treat hematological malignancies. Although clinical trials are already...
Autores principales: | Itoh, Kazuhiro, Shigemi, Hiroko, Kinoshita, Keiichi, Tsukasaki, Hikaru, Imamura, Shin, Morinaga, Koji, Yoshio, Nobuyuki, Nakayama, Takashi, Inoue, Hitoshi, Ueda, Takanori, Yamauchi, Takahiro, Iwasaki, Hiromichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646351/ https://www.ncbi.nlm.nih.gov/pubmed/35314551 http://dx.doi.org/10.2169/internalmedicine.9070-21 |
Ejemplares similares
-
Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study
por: Shalhoub, Sarah, et al.
Publicado: (2014) -
Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
por: Chong, Yong, et al.
Publicado: (2013) -
Multifaceted efficacy of caspofungin against fungal infections in COVID-19 patients
por: Itoh, Kazuhiro, et al.
Publicado: (2022) -
Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes
por: Raheja, Ronak, et al.
Publicado: (2023) -
Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)